// App-Quantinova.ai

: Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival

Researchers

Presenter

  • Marlijn Hoeks

Principal Investigators

  • Rian Roelofs

  • Louise De Swart

  • David Bowen

  • Argiris Symeonidis

  • Corine van Marrewijk

  • Eva Hellstrm-Lindberg

  • Aurelia Tatic

  • Saskia Langemeijer

  • Dominic J. Culligan

  • Marian Macheta

  • Hege Garelius

  • Michail Spanoudakis

  • Sally Killick

  • Panagiotis Panagiotidis

  • Oana Stanca Ciocan

  • Juliet Mills

  • Bryson Pottinger

  • Sam Ackroyd

  • Claire Hall

  • Jackie Droste

  • Alexandra Smith

  • Dorine W. Swinkels

  • Theo M de Witte

Medical Centers

  • Epidemiology and Cancer Statistics Group, University of York, York, United Kingdom

  • Dep. of Laboratory Medicine, Radboud university medical centre, Nijmegen, Netherlands

  • Rheumatology, Radboudumc, Nijmegen, Netherlands

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

  • Department of Internal Medicine, Division of Hematology, University of Patras Medical School, Patras, Greece

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • Center for Hematology and Regenerative Medicine (HERM), Department of Medicine, Karolinska Institutet, Stockholm, Sweden

  • Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania

  • Aberdeen Royal Infirmary, Aberdeen, United Kingdom

  • Department of Haematology, Blackpool Victoria Hospital, Blackpool, United Kingdom

  • Dep. of Medicine, Sect. of Hematology and Coagulation, Sahlgrenska University Hospital, Göteborg, Sweden

  • Airedale NHS Trust, Steeton, United Kingdom

  • The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, United Kingdom

  • Laikon Hospital, Athens, GRC

  • Colentina Hospital, Bucharest, Romania

  • Hematology,Acute Hospitals NHS Trust and University of Birmingham,Birmingham,United Kingdom

  • Dep. of Haematology, Royal Cornwall Hospital, Truro, United Kingdom

  • Bradford Royal Infirmary,Bradford, UK

  • Harrogate District Hospital, Harrogate, UK, Harrogate, United Kingdom

  • Dep. of Laboratory Medicine (TML 830), Radboud University Medical Centre, Nijmegen, Netherlands

  • Dep. of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, Netherlands

Locations

  • Netherlands

  • United Kingdom

  • Greece

  • Sweden

  • Romania

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelodysplastic Syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved